Pyrogen Testing Market Study by Injectable Therapeutics, Vaccines, Oral Pharmaceuticals, Biologics, Implantable Medical Devices, Dialysis Liquids, and Toxic/Immune-modulatory Drugs from 2024 to 2034

<p>The global pyrogen testing market is projected to increase from a valuation of <strong>US$ 1.96 billion</strong> in 2024 to <strong>US$ 6.53 billion</strong> by the end of 2034. Demand for pyrogen testing is analyzed to advance at a remarkable <strong>CAGR of 12.8%</strong> from 2024 to 2034.</p><table><thead><tr><th>Report Attribute</th><th>Detail</th></tr></thead><tbody><tr><td>Pyrogen Testing Market Size (2024E)</td><td>US$ 1.96 Billion</td></tr><tr><td>Forecasted Market Value (2034F)</td><td>US$ 6.53 Billion</td></tr><tr><td>Global Market Growth Rate (2024 to 2034)</td><td>12.8% CAGR</td></tr><tr><td>Canada Market Growth Rate (2024 to 2034)</td><td>14.3% CAGR</td></tr><tr><td>China Market Value (2034F)</td><td>US$ 636 Million</td></tr><tr><td>North America Market Share (2024E)</td><td>37.4%</td></tr><tr><td>East Asia Market Share (2034F)</td><td>19.1%</td></tr><tr><td>Key Companies Profiled</td><td>Promega Corporation; GenScript; ASSOCIATES OF CAPE COD, INC.,; BioM&eacute;rieux SA; Ellab A/S; Hycult Biotech; Eurofins Biolab Srl; SOLVIAS AG, Wickham Laboratories Ltd.; Nelson Laboratories, LLC; Charles River Laboratories, Creative Biolabs.</td></tr></tbody></table><p>Country-wise Evaluation</p><table><thead><tr><th>Attribute</th><th>United States</th></tr></thead><tbody><tr><td>Market Value (2024E)</td><td>US$ 685 Million</td></tr><tr><td>Growth Rate (2024 to 2034)</td><td>11.8% CAGR</td></tr><tr><td>Projected Value (2034F)</td><td>US$ 2.09 Billion</td></tr></tbody></table><table><thead><tr><th>Attribute</th><th>China</th></tr></thead><tbody><tr><td>Market Value (2024E)</td><td>US$ 128 Million</td></tr><tr><td>Growth Rate (2024 to 2034)</td><td>17.4% CAGR</td></tr><tr><td>Projected Value (2034F)</td><td>US$ 636 Million</td></tr></tbody></table><p>Category-wise Insights</p><table><thead><tr><th>Attribute</th><th>Test Kits &amp; Reagents</th></tr></thead><tbody><tr><td>Segment Value (2024E)</td><td>US$ 877.4 Million</td></tr><tr><td>Growth Rate (2024 to 2034)</td><td>14.1% CAGR</td></tr><tr><td>Projected Value (2034F)</td><td>US$ 3.28 Billion</td></tr></tbody></table><table><thead><tr><th>Attribute</th><th>In-Vitro Based</th></tr></thead><tbody><tr><td>Segment Value (2024E)</td><td>US$ 274.6 Million</td></tr><tr><td>Growth Rate (2024 to 2034)</td><td>14.3% CAGR</td></tr><tr><td>Projected Value (2034F)</td><td>US$ 1.04 Billion</td></tr></tbody></table>

<p>全球致热原检测市场规模预计将从2024年的估值<Strong>19.6亿美元</Strong>增长至2034年底的<Strong>65.3亿美元</Strong>。对致热原检测的需求分析显示，从2024年到2034年，其年复合增长率（CAGR）将显著达到12.8%。</p><table><thead><tr><th>报告属性</th><th>详情</th></tr></thead><tbody><tr><td>致热原检测市场规模（2024E）</td><td>19.6亿美元</td></tr><tr><td>预测市场规模（2034F）</td><td>65.3亿美元</td></tr><tr><td>全球市场规模增长率（2024至2034年）</td><td>12.8% CAGR</td></tr><tr><td>加拿大市场规模增长率（2024至2034年）</td><td>14.3% CAGR</td></tr><tr><td>中国市场规模（2034F）</td><td>6.36亿美元</td></tr><tr><td>北美市场占有率（2024E）</td><td>37.4%</td></tr><tr><td>东亚市场占有率（2034F）</td><td>19.1%</td></tr><tr><td>主要公司简介</td><td>Promega Corporation；GenScript；ASSOCIATES OF CAPE COD, INC.；BioMérieux SA；Ellab A/S；Hycult Biotech；Eurofins Biolab Srl；SOLVIAS AG, Wickham Laboratories Ltd.；Nelson Laboratories, LLC；Charles River Laboratories；Creative Biolabs。</td></tr></tbody></table><p>按国家评估</p><table><thead><tr><th>属性</th><th>美国</th></tr></thead><tbody><tr><td>市场规模（2024E）</td><td>6.85亿美元</td></tr><tr><td>增长率（2024至2034年）</td><td>11.8% CAGR</td></tr><tr><td>预测值（2034F）</td><td>20.9亿美元</td></tr></tbody></table><table><thead><tr><th>属性</th><th>中国</th></tr></thead><tbody><tr><td>市场规模（2024E）</td><td>1.28亿美元</td></tr><tr><td>增长率（2024至2034年）</td><td>17.4% CAGR</td></tr><tr><td>预测值（2034F）</td><td>6.36亿美元</td></tr></tbody></table><p>按类别洞察</p><table><thead><tr><th>属性</th><th>测试套件与试剂</th></tr></thead><tbody><tr><td>细分市场规模（2024E）</td><td>8.774亿美元</td></tr><tr><td>增长率（2024至2034年）</td><td>14.1% CAGR</td></tr><tr><td>预测值（2034F）</td><td>32.8亿美元</td></tr></tbody></table><table><thead><tr><th>属性</th><th>基于体外</th></tr></thead><tbody><tr><td>细分市场规模（2024E）</td><td>2.746亿美元</td></tr><tr><td>增长率（2024至2034年）</td><td>14.3% CAGR</td></tr><tr><td>预测值（2034F）</td><td>10.4亿美元</td></tr></tbody></table>